NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 165 filers reported holding NOVOCURE LTD in Q2 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $749,618 | +251.9% | 46,416 | +1413.9% | 0.09% | +57.9% |
| Q2 2022 | $213,000 | -60.6% | 3,066 | -57.4% | 0.06% | -69.2% |
| Q4 2021 | $541,000 | +87.8% | 7,200 | +453.8% | 0.18% | +55.5% |
| Q2 2021 | $288,000 | +20.0% | 1,300 | -54.4% | 0.12% | +60.8% |
| Q4 2019 | $240,000 | -0.4% | 2,848 | -25.2% | 0.07% | -32.1% |
| Q2 2019 | $241,000 | 0.0% | 3,805 | -50.6% | 0.11% | -41.1% |
| Q2 2018 | $241,000 | – | 7,700 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |